Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement
2005 ◽
Vol 61
(3)
◽
pp. 695-701
◽
2003 ◽
Vol 57
(2)
◽
pp. S150
◽
2012 ◽
Vol 82
(2)
◽
pp. 906-910
◽
1980 ◽
Vol 6
(2)
◽
pp. 149-153
◽
1995 ◽
Vol 86
(4)
◽
pp. 919-926
◽
2020 ◽
Vol 108
(3)
◽
pp. e860
2006 ◽
Vol 25
(4)
◽
pp. 344-346
Keyword(s):
Keyword(s):